Government invests $445m to protect older Australians from RSV

Older Australians will soon have free access to a Respiratory Syncytial Virus (RSV) vaccine, with the Albanese government announcing a major investment to protect those most at risk of severe illness from the common but potentially deadly virus.

From 15 May, Australians aged 75 and over, and Aboriginal and Torres Strait Islander people aged 60 and over, will be eligible for a free RSV vaccine through the National Immunisation Program (NIP).

The government has committed $445.3 million to fund access to the vaccine Arexvy, which would otherwise cost around $300 per dose.

Eligible people will be able to receive the vaccine through GPs, immunisation clinics, community and Aboriginal health services and participating pharmacies.

Health Minister Mark Butler said the program would help protect older Australians.

“Aged care residents and older First Nations people are particularly vulnerable to this common respiratory illness,” he said.

The new program complements existing free NIP vaccines for influenza and Covid‑19 designed to keep these vulnerable populations safer.

Minister Butler urged eligible people to book their flu vaccination as well, noting that influenza remains a serious threat for pregnant women, young children and adults over 65.

“No two influenza seasons are the same and the flu can spread all year round, so it is never too late to get vaccinated,” he said.

GPs welcome decision

The Royal Australian College of GPs (RACGP) has welcomed the announcement, calling it an important step in reducing preventable hospitalisations and improving health outcomes for older Australians.

RACGP President Dr Michael Wright said the decision follows strong advocacy from general practice.

“RSV can cause serious illness in older people, leading to hospitalisation, complications and, in some cases, death,” Dr Wright said.

“This decision will save lives, reduce pressure on hospitals and improve protection for those most at risk.”

He said the inclusion of Aboriginal and Torres Strait Islander people aged 60 and over recognised the higher burden of respiratory disease in these communities.

“This is a welcome and targeted decision that acknowledges the importance of equity in preventive healthcare,” he said.

“Ensuring vaccines are accessible to those who need them most is essential to closing health gaps.”

The RACGP said GPs will play a key role in delivering the RSV vaccine, alongside existing influenza and Covid‑19 programs.

“GPs are trusted by patients to provide tailored advice about vaccination and timing, particularly for older people with complex medical needs,” Dr Wright said.

“Including the RSV vaccine on the NIP supports continuity of care and ensures vaccination is delivered safely and effectively.”

The College encouraged eligible Australians to speak with their GP about RSV vaccination as part of their broader immunisation and health plan.